NLS Pharmaceutics (NLS Pharmaceutics) Other Long Term Assets : $0.02 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Other Long Term Assets?

NLS Pharmaceutics's other long-term assets for the quarter that ended in Dec. 2023 was $0.02 Mil.

NLS Pharmaceutics's quarterly other long-term assets increased from Dec. 2022 ($0.01 Mil) to Jun. 2023 ($0.01 Mil) and increased from Jun. 2023 ($0.01 Mil) to Dec. 2023 ($0.02 Mil).

NLS Pharmaceutics's annual other long-term assets increased from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.01 Mil) and increased from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($0.02 Mil).

NLS Pharmaceutics Other Long Term Assets Historical Data

The historical data trend for NLS Pharmaceutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Other Long Term Assets Chart

NLS Pharmaceutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.31

1.02

0.01

0.02

NLS Pharmaceutics Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial								0.01	0.01	0.01	0.01	0.02

NLS Pharmaceutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.